General Information of Drug (ID: DMJBU9V)

Drug Name
Velimogene aliplasmid Drug Info
Synonyms Allovectin (TN)
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Phase 3 [1]
Cross-matching ID
TTD Drug ID
DMJBU9V

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
HLA class I antigen B-7 (HLA-B) TTGS10J 1B07_HUMAN Modulator [2]

References

1 ClinicalTrials.gov (NCT00050388) Phase II Trial of Allovectin-7 for Head and Neck Cancer. U.S. National Institutes of Health.
2 Velimogene aliplasmid. Expert Opin Biol Ther. 2010 May;10(5):841-51.